Skip to main content
Download PDF

Toxoplasma gondii exposure in patients suffering from mental and behavioral disorders due to psychoactive substance use

BMC Infectious Diseases volume 15, Article number: 172 (2015) Cite this article

Abstract

Background

Toxoplasma gondii infection has been associated with psychiatric diseases. However, there is no information about the link between this infection and patients with mental and behavioral disorders due to psychoactive substance use.

Methods

We performed a case-control study with 149 psychiatric patients suffering from mental and behavioral disorders due to psychoactive substance use and 149 age- and gender-matched control subjects of the general population. We searched for anti-T. gondii IgG and IgM antibodies in the sera of participants by means of commercially available enzyme-linked immunoassays. Seroprevalence association with socio-demographic, clinical and behavioral characteristics in psychiatric patients was also investigated.

Results

Anti-T. gondii IgG antibodies were present in 15 (10.1%) of 149 cases and in 14 (9.4%) of 149 controls (P = 1.0). Anti-T. gondii IgM antibodies were found in 11 (7.4%) of the 149 cases and in 16 (10.7%) of the 149 controls (P = 0.31). No association of T. gondii exposure with socio-demographic characteristics of patients was found. Multivariate analysis of clinical and behavioral characteristics of cases showed that T. gondii seropositivity was positively associated with consumption of opossum meat (OR = 10.78; 95% CI: 2.16-53.81; P = 0.003) and soil flooring at home (OR = 11.15; 95% CI: 1.58-78.92; P = 0.01), and negatively associated with suicidal ideation (OR = 0.17; 95% CI: 0.05-0.64; P = 0.008).

Conclusions

Mental and behavioral disorders due to psychoactive substance use do not appear to represent an increased risk for T. gondii exposure. This is the first report of a positive association of T. gondii exposure with consumption of opossum meat. Further studies to elucidate the role of T. gondii infection in suicidal ideation and behavior are needed to develop optimal strategies for the prevention of infection with T. gondii.

Peer Review reports

Background

Toxoplasma gondii infection is a common zoonotic infection all around the world [1]. Infection with T. gondii is usually acquired by ingesting water or food contaminated with parasite oocysts shed by cats or by ingestion of raw or undercooked meat containing parasite tissue cysts [2]. Less commonly, T. gondii infection has been associated with blood transfusion [3] or transplantation [4,5]. Although most T. gondii infected people shows no symptoms, some infected individuals may develop toxoplasmosis, which is a disease with involvement of eyes, lymph nodes and central nervous system [1,2,6]. Toxoplasmosis in immunocompromised patients may be a life-threatening disease [2,7]. In addition, congenital toxoplasmosis may occur after primary T. gondii infection during pregnancy [2,8,9].

Infection with T. gondii has been associated with some psychiatric disorders including schizophrenia [10-12], personality disorders [13], and obsessive-compulsive disorder [14]. However, the association of T. gondii infection with mental and behavioral disorders due to psychoactive substance use has not been studied. In a previous descriptive study in psychiatric patients, we found that 4 of 26 patients with mental and behavioral disorders due to psychoactive substance use had T. gondii antibodies [10]. However, the study design (cross-sectional) and the small sample size did not allow us properly assessing the association of infection and disease. Therefore, in the present study, we sought to determine the association of T. gondii infection with patients suffering from mental and behavioral disorders due to psychoactive substance use attended in the psychiatric hospital of Durango City, Mexico. Furthermore, the association of T. gondii infection with the socio-demographic, clinical and behavioral characteristics of the patients was also investigated.

Methods

Study design and study populations

We performed a case-control seroprevalence study in 149 patients suffering from mental and behavioral disorders due to psychoactive substance use (cases) and 149 people from the general population (controls) in Durango City, Mexico from November 2013 to August 2014. Inclusion criteria for the cases were patients suffering from mental and behavioral disorders due to psychoactive substance use attended in the Hospital of Mental Health “Dr. Miguel Vallebueno” in Durango City, aged 18 years and older, and who voluntarily accepted to participate in the study. Gender was not a restrictive criterion for enrollment. Cases were 18-67 (mean = 36.01 ± 12.48) years old, and included 123 males and 26 females. Mental and behavioral disorders in the 149 patients studied were due to use of alcohol (F10) in 38 patients, use of cannabinoids (F12) in 8, use of sedative hypnotics (F13) in 7, use of cocaine (F14) in 1, use of other stimulants including caffeine (F15) in 3, use of tobacco (F17) in 10, and multiple drugs use and use of other psychoactive substances (F19) in 82. Exclusion criterion for the cases was presence of severe illness that impairs their decision to participate in the study. Control subjects were randomly selected from the general population in Durango City. Controls were recruited from homes, schools, work places and streets as previously described [15,16]. Controls were matched with cases by age (±1 year) and gender. Controls were 18-67 (mean = 36.03 ± 12.49) years old, and included 123 males and 26 females. There was no difference in age between cases and controls (P = 0.98).

Socio-demographic, clinical, and behavioral data in cases

Patients submitted a standardized questionnaire in order to obtain their socio-demographic, clinical, and behavioral characteristics. Socio-demographic data obtained included age, gender, birthplace, residence, educational level, occupation, and socioeconomic status. Items of clinical characteristics were health status, history of lymphadenopathy, blood transfusions, transplantation and surgeries, presence of frequent headache, dizziness, and impairments in vision, hearing, memory and reflexes. In female patients, obstetric history was also obtained. In addition, the area of attention (outpatients or inpatients), the psychiatric diagnosis, evolution time, presence of treatment, response to treatment, and history of aggressiveness, suicidal ideation and suicide attempt from the patients were recorded. Psychiatric diagnosis was based on the ICD-10 classification [17]. Behavioral data included contact with animals, foreign traveling, frequency of meat consumption, type of meat consumed (pork, beef, goat, lamb, boar, chicken, turkey, pigeon, duck, rabbit, venison, squirrel, horse, opossum, or other), consumption of raw or undercooked meat and dried or processed meat (ham, sausages or chorizo), drinking untreated water or unpasteurized milk, consumption of unwashed raw vegetables and fruits, frequency of eating away from home (in restaurants or fast food outlets), contact with soil (gardening or agriculture), and type of flooring at home.

Serological detection of T. gondii antibodies

Sera from participants were analyzed for anti-T. gondii IgG antibodies with the commercially available enzyme immunoassay kit “Toxoplasma IgG” (Diagnostic Automation Inc., Calabasas, CA, USA). This test allows determining the presence and levels of IgG antibodies. A positive result was considered when a value of equal to or higher than 8 IU/ml of specific anti-T. gondii IgG antibody was obtained. All sera were further analyzed for anti-T. gondii IgM antibodies by the commercially available enzyme immunoassay “Toxoplasma IgM” kit (Diagnostic Automation Inc., Calabasas, CA, USA). All tests were performed following the instructions of the manufacturer.

Statistical analysis

Data was analyzed with the following software: Microsoft Excel 2010, Epi Info version 7 (Centers for Disease Control and Prevention: http://wwwn.cdc.gov/epiinfo/) and SPSS version 15.0 (SPSS Inc. Chicago, Illinois). For calculation of the sample size, we used a 95% confidence level, a power of 80%, a 1:1 proportion of cases and controls, a reference seroprevalence of 6.1% [15] as the expected frequency of exposure in controls, and an odds ratio of 3.0. The result of the sample size calculation was 149 cases and 149 controls. The paired student’s t test was used to compare age values among the groups. The McNemar’s test was used for comparison of the frequencies of seropositivity to T. gondii between cases and controls. The initial evaluation of the association between the seropositivity to T. gondii and the characteristics of the patients was performed with the Pearson’s chi-square test and the Fisher exact test (when values were small). Variables with a P value ≤0.10 obtained in the bivariate analysis were further analyzed to determine their association with T. gondii infection by multivariate analysis. Odds ratios (OR) and 95% confidence intervals (CI) were calculated by means of the backward stepwise regression method. We used the Hosmer-Lemeshow goodness of fit test to assess the fitness of the regression model. Statistical significance was set at a P value of less than 0.05.

Ethics aspects

This study was approved by the Ethical Committee of the Institute for Scientific Research “Dr. Roberto Rivera Damm”, Juárez University of Durango State. The purpose and procedures of the study were explained to all participants. In addition, a written informed consent was obtained from each participant.

Results

Anti-T. gondii IgG antibodies were present in 15 (10.1%) of 149 cases and in 14 (9.4%) of 149 controls. There was not difference in the seroprevalence of T. gondii infection among case control pairs (OR = 3.0; 95% CI: 0.12-73.64; P = 1.0). Of the 15 anti-T. gondii IgG positive cases, 13 (8.7%) had anti-T. gondii IgG antibody levels higher than 150 IU/ml, and 2 (1.3%) between 8 to 99 IU/ml. In contrast, of the 14 anti-T. gondii IgG positive controls, 7 (4.7%) had anti-T. gondii IgG antibody levels higher than 150 IU/ml, 1 (0.7%) between 100 to 150 IU/ml, and 6 (4.0%) between 8 to 99 IU/ml. The frequency of high (>150 IU/ml) levels of anti-T. gondii IgG antibodies was similar among cases and controls (P = 0.24). Anti-T. gondii IgM antibodies were found in 11 (7.4%) of the 149 cases and in 16 (10.7%) of the 149 controls (P = 0.31). Anti-T. gondii IgG antibodies were detected in 1 (3.8%) of 26 female cases and in 3 (11.5%) of 26 female controls (P = 0.60). While anti-T. gondii IgG antibodies were detected in 14 (11.4%) of 123 male cases and in 11 (8.9%) of 123 male controls (P = 0.52). The frequency of high (>150 IU/ml) anti-T. gondii IgG antibody levels was similar in male (12/123: 9.8%) and female (1/26: 3.8%) cases (P = 0.46).

With respect to the socio-demographic characteristics in cases, none of the variables studied (age, gender, birthplace, residence, occupation, educational level and socioeconomic status) had a P value ≤0.10 by bivariate analysis (Table 1).

Table 1 Socio-demographic characteristics of psychiatric patients with psychoactive substance use and seroprevalence of T. gondii infection
Full size table

Of the clinical characteristics in cases, seropositivity to T. gondii was not associated with the area of attention (outpatients or inpatients), psychiatric diagnosis, evolution time, response to treatment, presence of other diseases, history of lymphadenopathy, blood transfusions, transplantation and surgeries, presence of frequent headaches, dizziness, and impairments in vision, hearing, memory and reflexes, or obstetric history in women. In contrast, seropositivity to T. gondii was negatively associated with aggressiveness, suicidal ideation and suicide attempts by bivariate analysis (Table 2). The prevalence of high (>150 IU/ml) anti-T. gondii IgG antibody levels was also lower in patients with aggressiveness (5/99, 5.1%) than in those (8/50, 16%) without aggressiveness (P = 0.03), and in patients with suicide ideation (5/99, 5.1%) than in those (8/50, 16%) without suicide ideation (P = 0.03). The frequency of high (>150 IU/ml) anti-T. gondii IgG antibody levels was lower (but not statistically significant) in patients with suicide attempt (2/57, 3.5%) than in those (11/92, 12%) without suicide attempt (P = 0.13).

Table 2 Clinical characteristics of psychiatric patients with psychoactive substance use and seroprevalence of T. gondii infection
Full size table

A selection of behavioral variables in cases and controls and their association with T. gondii seropositivity is shown in Table 3. Of the behavioral characteristics in cases, the variables cats in the neighborhood, dogs at home, consumption of meat from boar, duck, opossum, and armadillo, eating unwashed raw vegetables, and soil flooring at home had P values ≤ 0.10 by bivariate analysis. Other behavioral characteristics including cats at home, cleaning cat excrement, traveling, consumption of pork, beef, venison, lamb, or meat from goat, chicken, turkey, pigeon, or squirrel, frequency of meat consumption, consumption of dried or processed meat, drinking unpasteurized milk or untreated water, consumption of unwashed raw fruits, and contact with soil had P values > 0.10. Multivariate analysis of clinical and behavioral characteristics of cases with P values ≤ 0.10 in the bivariate analysis showed that seropositivity to T. gondii was positively associated with consumption of opossum meat (OR = 10.78; 95% CI: 2.16-53.81; P = 0.003) and soil flooring at home (OR = 11.15; 95% CI: 1.58-78.92; P = 0.01), and negatively associated with suicidal ideation (OR = 0.17; 95% CI: 0.05-0.64; P = 0.008). The result of the Hosmer-Lemeshow test (P = 0.96) indicated a good fit of our regression model.

Table 3 Bivariate analysis of selected putative risk factors for infection with T. gondii in psychiatric patients with psychoactive substance use and controls
Full size table

Discussion

There are no reports on the association of T. gondii infection with mental and behavioral disorders due to psychoactive substance use. Therefore, through an age- and gender matched case-control study design we sought to determine such association in patients attended in a psychiatric hospital in northern Mexico. The seroprevalence of anti-T. gondii IgG and IgM antibodies and anti-T. gondii antibody levels were similar in patients than in the general population. Thus, our results suggest that mental and behavioral disorders due to psychoactive substance use are not associated with infection with T. gondii. Whether T. gondii infection might predispose to drug use or whether drug use might predispose to T. gondii infection is unknown. The 10.1% seroprevalence of T. gondii infection found in patients suffering from mental and behavioral disorders due to psychoactive substance use is comparable to the 7.4% seroprevalence of T. gondii infection reported in healthy blood donors in Durango City [18] but it is lower than that (21.1%) reported in waste pickers [19] and inmates [20]. Differences in contributing factors for infection among the groups may explain the differences in the seroprevalences. Altogether, results indicate that mental and behavioral disorders due to psychoactive substance use do not predispose to infection with T. gondii. In contrast, high seroprevalence (18.2%) of T. gondii infection has been reported in psychiatric patients [10], and therefore, the low seroprevalence (10.1%) found in the present study was unexpected. Reported contributing factors for T. gondii infection in psychiatric patients include sexual promiscuity, consumption of unwashed raw fruits, and history of surgery [10]. These factors were not associated with T. gondii infection in the present study. The underlying mechanisms mediating a potential association of T. gondii infection with mental and behavioral disorders due to psychoactive substance use have not been elucidated. Infection with T. gondii may lead to behavioral changes in humans and animals and these changes have been reviewed recently [21,22]. The seroepidemiology of T. gondii infection among drug addicts has been poorly explored. Seroprevalence of T. gondii infection in intravenous drug addicts was 7.7% in Vietnam [23] and 47.6% in Spain [24]. However, these studies did not provide information about a correlation of T. gondii infection with mental and behavioral disorders due to psychoactive substance use.

We assessed a number of putative risk factors for T. gondii exposure. However, none of the socio-demographic characteristics of patients was associated with T. gondii seropositivity. In contrast, multivariate analysis showed that T. gondii exposure was positively associated with consumption of opossum meat and living in a house with soil flooring. The epidemiological link of consumption of opossum meat and T. gondii exposure is highly feasible since 16.6% of native opossums (Didelphis virginiana) in Durango were found positive for anti-T. gondii antibodies by using the modified agglutination test [25]. In addition, seropositivity to T. gondii has been found in several species of opossums [26]. Recently, isolation of T. gondii was obtained in a black-eared opossum (Didelphis aurita) from Brazil [27]. Of note, seroprevalence of T. gondii infection was also associated with consumption of armadillo meat by bivariate analysis. However, this association did not resist the multivariate analysis. On the other hand, the association of T. gondii seroprevalence with living in a house with soil flooring found in the present study confirms previous observations in pregnant women in urban [28] and rural [29] Durango, Mexico. A contamination of soil floors at home with parasite oocyst might have occurred in these cases.

Of the clinical characteristics, T. gondii exposure was not associated with any specific type or subtype of mental and behavioral disorders due to psychoactive substance use. Intriguingly, aggressiveness, suicidal ideation and suicide attempts were negatively associated with seropositivity to T. gondii by bivariate analysis. Further analysis by logistic regression showed that T. gondii exposure was negatively associated with suicidal ideation. This result was unexpected since T. gondii seropositivity has been associated with suicide attempts [30,31]. In a recent study in psychiatric patients in Durango City, we found an association of high anti-T. gondii IgG levels with suicide attempts [32]. It is not clear why T. gondii exposure was negatively associated with suicidal ideation in patients suffering from mental and behavioral disorders due to psychoactive substance use in this study. Differences in the populations among the studies might account for explaining the apparently conflicting results. Depression rate was higher in the previously studied population than in patients in the present study. In addition, in the previous study, we sampled patients with a number of psychiatric disorders while in the present study we only sampled patients suffering from mental and behavioral disorders due to psychoactive substance use. It raises a question whether psychoactive substance use influences the rate of suicide behavior in T. gondii infected patients. Remarkably, both T. gondii infection and psychotropic drugs influence the dopaminergic pathways. Infection with T. gondii has been associated with an increase in dopamine in brain [33]. Most drugs of abuse increase the dopamine neurotransmission [34]. In contrast, a reduced dopamine synthesis in marihuana users has been found [35]. On the other hand, dopamine and serotonin have been involved in suicide behavior and aggression [36]. Therefore, alterations in neurotransmitters as dopamine due to T. gondii infection and substance use could be influencing the rate of aggressiveness and suicide behavior in our patients. Both substance use [37] and high levels of anti-T. gondii IgG antibodies [32] have been associated with suicide attempts in psychiatric patients in our region. However, the negative association of T. gondii infection with suicide ideation found in patients suffering from mental and behavioral disorders due to psychoactive substance use suggests a protective effect of T. gondii against suicide ideation in these patients. Interestingly, a negative effect of latent toxoplasmosis on the suicide-associated burden in non-European countries was recently reported [38]. Most of the studied patients in the current study used several drugs but marihuana use was common among them. It raises the question whether the reduced dopamine synthesis in marihuana users might be somewhat overcame for an increase in dopamine production by T. gondii resulting in normal levels of dopamine and low rates of suicide ideation. On the other hand, it is unknown whether an overproduction of dopamine by both T. gondii infection and some psychotropic substances might also lead to a reduction of suicide ideation rates. The role of T. gondii in the production of neurotransmitters and their interactions has been scantly studied. Apart from dopamine, other neurotransmitters might play a role in suicide behavior. Low cerebrospinal fluid concentrations of 5-hydroxyindolacetic acid has been associated with suicidal behavior [39,40]. Whether production of dopamine (and perhaps other neurotransmitters) by T. gondii is compensating excitatory or inhibitory effects of neurotransmitters associated with suicide behavior should be elucidated. Infections with T. gondii or HIV/T. gondii co-infections in intravenous drug users have correlated with altered serum cytokine levels including increased levels of TNF-α, IL-6 and IL-12 [41]. Further studies with a different study design to assess the negative association of T. gondii exposure with suicidal behavior in patients suffering from mental and behavioral disorders due to psychoactive substance use is needed.

In the present study, analysis of the association of T. gondii infection with the characteristics of the patients was based on results of anti-T. gondii IgG antibodies. In fact, anti-T. gondii IgG antibodies appear very early after infection [42]. Results of anti-T. gondii IgM antibodies were not included in the analysis because of a number of limitations for the diagnosis of T. gondii infection. Firstly, tests for detection of anti-T. gondii IgM antibodies may have a high rate of false positive results caused by limitations in test specificity [43]. Therefore, interpretation of the increased IgM seroprevalence found in the current study should be taken with care. Secondly, the absence of anti-T. gondii IgM in subjects with anti-T. gondii IgG antibodies indicates a chronic infection but the presence of the IgM marker does not necessarily indicate an acute infection. Anti-T. gondii IgM antibodies are detectable early after infection and can persist for prolonged periods of time after infection [2,43]. Therefore, seropositivity to IgM alone is not considered an acceptable diagnostic criterion for acute infection.

Conclusions

We conclude that infection with T. gondii is not associated with mental and behavioral disorders due to psychoactive substance use. This is the first report of a positive association of T. gondii exposure with consumption of opossum meat. Further studies to elucidate the role of T. gondii infection in suicidal ideation and behavior are needed to develop optimal strategies for the prevention of infection with T. gondii.

References

  1. Dubey JP. Toxoplasmosis of animals and humans. 2nd ed. Boca Raton, Florida: CRC Press; 2010.

    Google Scholar 

  2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–76.

    Article  CAS  PubMed  Google Scholar 

  3. Alvarado-Esquivel C, Liesenfeld O, Márquez-Conde JA, Estrada-Martínez S, Dubey JP. Seroepidemiology of infection with Toxoplasma gondii in workers occupationally exposed to water, sewage, and soil in Durango, Mexico. J Parasitol. 2010;96:847–50.

    Article  CAS  PubMed  Google Scholar 

  4. Strabelli TM, Siciliano RF, Vidal Campos S, Bianchi Castelli J, Bacal F, Bocchi EA, et al. Toxoplasma gondii myocarditis after adult heart transplantation: successful prophylaxis with pyrimethamine. J Trop Med. 2012;2012:853562.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Osthoff M, Chew E, Bajel A, Kelsey G, Panek-Hudson Y, Mason K, et al. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient. Transpl Infect Dis. 2013;15:E14–9.

    Article  CAS  PubMed  Google Scholar 

  6. Maenz M, Schlüter D, Liesenfeld O, Schares G, Gross U, Pleyer U. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. 2014;39:77–106.

    Article  CAS  PubMed  Google Scholar 

  7. Munoz M, Liesenfeld O, Heimesaat MM. Immunology of Toxoplasma gondii. Immunol Rev. 2011;240:269–85.

    Article  CAS  PubMed  Google Scholar 

  8. Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Alvarado-Esquivel C, Pacheco-Vega SJ, Hernández-Tinoco J, Centeno-Tinoco MM, Beristain-García I, Sánchez-Anguiano LF, et al. Miscarriage history and Toxoplasma gondii infection: a cross-sectional study in women in Durango City, Mexico. Eur J Microbiol Immunol (Bp). 2014;4:117–22.

    Article  CAS  Google Scholar 

  10. Alvarado-Esquivel C, Alanis-Quiñones OP, Arreola-Valenzuela MA, Rodríguez-Briones A, Piedra-Nevarez LJ, Duran-Morales E, et al. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis. 2006;6:178.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology. 2005;38:87–90.

    Article  CAS  PubMed  Google Scholar 

  12. Alvarado-Esquivel C, Urbina-Álvarez JD, Estrada-Martínez S, Torres-Castorena A, Molotla-de-León G, Liesenfeld O, et al. Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population. Parasitol Int. 2011;60:151–5. doi:10.1016/j.parint.2010.12.003.

    Article  PubMed  Google Scholar 

  13. Hinze-Selch D, Däubener W, Erdag S, Wilms S. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha). 2010;57:129–35.

    Article  CAS  Google Scholar 

  14. Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Res. 2010;177:263–5. doi:10.1016/j.psychres.2009.12.013.

    Article  PubMed  Google Scholar 

  15. Alvarado-Esquivel C, Estrada-Martínez S, Pizarro-Villalobos H, Arce-Quiñones M, Liesenfeld O, Dubey JP. Seroepidemiology of Toxoplasma gondii infection in general population in a northern Mexican city. J Parasitol. 2011;97:40–3.

    Article  CAS  PubMed  Google Scholar 

  16. Alvarado-Esquivel C, Pacheco-Vega SJ, Hernández-Tinoco J, Saldaña-Simental DE, Sánchez-Anguiano LF, Salcedo-Jáquez M, et al. Lack of association between Toxoplasma gondii infection and occupational exposure to animals. Eur J Microbiol Immunol (Bp). 2014;4:184–92. doi: 10.1556/EUJMI-D-14-00024.

    Article  Google Scholar 

  17. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.

    Google Scholar 

  18. Alvarado-Esquivel C, Mercado-Suarez MF, Rodríguez-Briones A, Fallad-Torres L, Ayala-Ayala JO, Nevarez-Piedra LJ, et al. Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango. Mexico BMC Infect Dis. 2007;7:75.

    Article  PubMed  Google Scholar 

  19. Alvarado-Esquivel C, Liesenfeld O, Márquez-Conde JA, Cisneros-Camacho A, Estrada-Martínez S, Martínez-García SA, et al. Seroepidemiology of infection with Toxoplasma gondii in waste pickers and waste workers in Durango, Mexico. Zoonoses Public Health. 2008;55:306–12.

    Article  CAS  PubMed  Google Scholar 

  20. Alvarado-Esquivel C, Hernández-Tinoco J, Sánchez-Anguiano LF, Ramos-Nevárez A, Cerrillo-Soto SM, Sáenz-Soto L, et al. High seroprevalence of Toxoplasma gondii infection in inmates: a case control study in Durango City, Mexico. Eur J Microbiol Immunol (Bp). 2014;4:76–82.

    Article  CAS  Google Scholar 

  21. Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol. 2013;216:127–33. doi:10.1242/jeb.073635.

    Article  PubMed  Google Scholar 

  22. Webster JP, Kaushik M, Bristow GC, McConkey GA. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? J Exp Biol. 2013;216:99–112. doi:10.1242/jeb.074716.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Buchy P, Follézou JY, Lien TX, An TT, Tram LT, Tri DV, et al. Serological study of toxoplasmosis in Vietnam in a population of drug users (Ho Chi Minh City) and pregnant women (Nha Trang). Bull Soc Pathol Exot. 2003;96:46–7.

    CAS  PubMed  Google Scholar 

  24. Gutiérrez J, Roldán C, Maroto MC. Seroprevalence of human toxoplasmosis. Microbios. 1996;85:73–5.

    PubMed  Google Scholar 

  25. Dubey JP, Velmurugan GV, Alvarado-Esquivel C, Alvarado-Esquivel D, Rodríguez-Peña S, Martínez-García S, et al. Isolation of Toxoplasma gondii from animals in Durango, Mexico. J Parasitol. 2009;95:319–22. doi:10.1645/GE-1874.1.

    Article  CAS  PubMed  Google Scholar 

  26. Siqueira DB, Aléssio FM, Mauffrey JF, Marvulo MF, Ribeiro VO, Oliveira RL, et al. Seroprevalence of Toxoplasma gondii in wild marsupials and rodents from the Atlantic forest of Pernambuco State, northeastern region, Brazil. J Parasitol. 2013;99:1140–3. doi:10.1645/GE-2855.1.

    Article  CAS  PubMed  Google Scholar 

  27. Pena HF, Marvulo MF, Horta MC, Silva MA, Silva JC, Siqueira DB, et al. Isolation and genetic characterisation of Toxoplasma gondii from a red-handed howler monkey (Alouatta belzebul), a jaguarundi (Puma yagouaroundi), and a black-eared opossum (Didelphis aurita) from Brazil. Vet Parasitol. 2011;175:377–81. doi:10.1016/j.vetpar.2010.10.015.

    Article  CAS  PubMed  Google Scholar 

  28. Alvarado-Esquivel C, Sifuentes-Alvarez A, Narro-Duarte SG, Estrada-Martínez S, Díaz-García JH, Liesenfeld O, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis. 2006;6:113.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Alvarado-Esquivel C, Torres-Castorena A, Liesenfeld O, García-López CR, Estrada-Martínez S, Sifuentes-Alvarez A, et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in rural Durango, Mexico. J Parasitol. 2009;95:271–4. doi:10.1645/GE-1829.1.

    Article  CAS  PubMed  Google Scholar 

  30. Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis. 2009;197:905–8. doi:10.1097/NMD.0b013e3181c29a23.

    Article  PubMed  Google Scholar 

  31. Yagmur F, Yazar S, Temel HO, Cavusoglu M. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int. 2010;199:15–7. doi:10.1016/j.forsciint.2010.02.020.

    Article  PubMed  Google Scholar 

  32. Alvarado-Esquivel C, Sánchez-Anguiano LF, Arnaud-Gil CA, López-Longoria JC, Molina-Espinoza LF, Estrada-Martínez S, et al. Toxoplasma gondii infection and suicide attempts: a case-control study in psychiatric outpatients. J Nerv Ment Dis. 2013;201:948–52. doi:10.1097/NMD.0000000000000037.

    Article  PubMed  Google Scholar 

  33. Xiao J, Li Y, Prandovszky E, Karuppagounder SS, Talbot Jr CC, Dawson VL, et al. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience. 2014;268:128–38. doi:10.1016/j.neuroscience.2014.03.015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Vander Weele CM, Porter-Stransky KA, Mabrouk OS, Lovic V, Singer BF, Kennedy RT, et al. Rapid dopamine transmission within the nucleus accumbens: Dramatic difference between morphine and oxycodone delivery. Eur J Neurosci. 2014;40:3041–54. doi:10.1111/ejn.12709.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Bloomfield MA, Morgan CJ, Kapur S, Curran HV, Howes OD. The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. Psychopharmacology (Berl). 2014;231:2251–9. doi:10.1007/s00213-014-3523-4.

    Article  CAS  Google Scholar 

  36. Ryding E, Lindström M, Träskman-Bendz L. The role of dopamine and serotonin in suicidal behaviour and aggression. Prog Brain Res. 2008;172:307–15. doi:10.1016/S0079-6123(08)00915-1.

    Article  CAS  PubMed  Google Scholar 

  37. Alvarado-Esquivel C, Sánchez-Anguiano LF, Arnaud-Gil CA, Hernández-Tinoco J, Molina-Espinoza LF, Rábago-Sánchez E. Socio-demographic, clinical and behavioral characteristics associated with a history of suicide attempts among psychiatric outpatients: a case control study in a northern Mexican City. Int J Biomed Sci. 2014;10:61–8.

    PubMed  PubMed Central  Google Scholar 

  38. Flegr J, Prandota J, Sovičková M, Israili ZH. Toxoplasmosis--a global threat: correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9:e90203. doi: 10.1371/journal.pone.0090203.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Asberg M. Neurotransmitters and suicidal behavior: the evidence from cerebrospinal fluid studies. Ann N Y Acad Sci. 1997;836:158–81.

    Article  CAS  PubMed  Google Scholar 

  40. Pandey GN. Biological basis of suicide and suicidal behavior. Bipolar Disord. 2013;15:524–41. doi:10.1111/bdi.12089.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Li JR, Gong RY, Li YP, Bai Y, You F, Deng S. Research on HIV/Toxoplasma gondii co-infection and cytokine levels among intravenous drug users. Parasite Immunol. 2010;32:161–4. doi:10.1111/j.1365-3024.2009.01174.x.

    Article  PubMed  Google Scholar 

  42. Pfrepper KI, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, et al. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol. 2005;12:977–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, et al. False-positive results in immunoglobulin M (IgM) Toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol. 1997;35:174–8.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was financially supported by Juarez University of Durango State.

Author information

Authors and Affiliations

  1. Biomedical Research Laboratory, Faculty of Medicine and Nutrition, Juárez University of Durango State, Avenida Universidad S/N, 34000, Durango, Mexico

    Cosme Alvarado-Esquivel, Sandy Janet Pacheco-Vega & Misael Salcedo-Jaquez

  2. Hospital of Mental Health “Dr. Miguel Vallebueno”, Secretary of Health, Avenida Fidel Velázquez S/N, 34234, Durango, Mexico

    David Carrillo-Oropeza & María Nalleli Ortiz-Jurado

  3. Institute for Scientific Research “Dr. Roberto Rivera-Damm”, Juárez University of Durango State, Avenida Universidad S/N, 34000, Durango, Mexico

    Jesús Hernández-Tinoco & Luis Francisco Sánchez-Anguiano

  4. Faculty of Nursing and Obstetrics, Juárez University of Durango State, Avenida Cuauhtémoc 223, 34000, Durango, Mexico

    Yesenia Alarcón-Alvarado & Isabel Beristain-García

  5. Institute for Microbiology and Hygiene, Campus Benjamin Franklin, Charité Medical School, Hindenburgdamm 27, D-12203, Berlin, Germany

    Oliver Liesenfeld

  6. Current address: Chief Medical Officer, Medical and Scientific Affairs, Roche Molecular Systems, Pleasanton, CA, 94588, USA

    Oliver Liesenfeld

Authors
  1. Cosme Alvarado-Esquivel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Carrillo-Oropeza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandy Janet Pacheco-Vega
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jesús Hernández-Tinoco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Misael Salcedo-Jaquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luis Francisco Sánchez-Anguiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. María Nalleli Ortiz-Jurado
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yesenia Alarcón-Alvarado
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Oliver Liesenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Isabel Beristain-García
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cosme Alvarado-Esquivel.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

CAE conceived and designed the study protocol, performed the laboratory tests, analyzed the data, and wrote the manuscript. DCO, SJPV, MSJ, YAA and IBG obtained the blood samples and clinical data, and/or performed the data analysis. JHT, LFSA and OL performed the data analysis and wrote the manuscript. MNOJ obtained the clinical data and performed the data analysis. All authors read and approved the final version of the manuscript.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Alvarado-Esquivel, C., Carrillo-Oropeza, D., Pacheco-Vega, S.J. et al. Toxoplasma gondii exposure in patients suffering from mental and behavioral disorders due to psychoactive substance use. BMC Infect Dis 15, 172 (2015). https://doi.org/10.1186/s12879-015-0912-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-015-0912-1

Keywords

  • Toxoplasma gondii
  • Infection
  • Seroprevalence
  • Psychiatric patients
  • Psychoactive drug Abuse
  • Epidemiology
  • Mexico

Comments

BMC Infectious Diseases

ISSN: 1471-2334

Contact us